Stock selection in health care equipment was a 100-plus basis point drag on performance, owing to notable declines from iRhythm Technologies, Inc. (IRTC) and Edwards Lifesciences Corporation (EW).
Recent Mentions
Recent Mentions
Recent articles, blogs, and social posts pertaining to this stock
Sources
Mentions
Mentions of this stock across all news source scraped in the past 30 days
Recent Mentions
Recent articles, blogs, and social posts pertaining to this stock
zacks.com
33.33%
SeekingAlpha
33.33%
seekingalpha.com
33.33%
•
•
•
•
•
•
•
•
Country
US
Industry
Health Care
Market Cap
Mid Cap
Num. Employees
98
IPO Date
Feb 4, 2022
Country
US
Industry
Health Care
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company is headquartered in Gaithersburg, Maryland and currently employs 98 full-time employees. The company went IPO on 2022-02-04. The firm is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM). The firm is also developing two clinical-stage ARC-SparX programs in Phase I trials; ACLX-001, which targets BCMA in rrMM, and ACLX-002, which targets CD123 in relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Outside of multiple myeloma (MM), the Company advances its wholly owned portfolio of clinical-stage, ACLX-002, and preclinical pipeline programs incorporating its D-Domain technology.
News Sentiment
Sentiment
Composite sentiment (positive vs. negative language) expressed across news sources mentioning this stock
Today
Recent Mentions
Recent articles, blogs, and social posts pertaining to this stock
Low Data
Related Stocks
Related Stocks
Stocks being mentioned with ACLX